Intensity Therapeutics (INTS) Interest & Investment Income (2022 - 2026)
Intensity Therapeutics' Interest & Investment Income came in at $77,000 for Q2 2026, up 352.9% from $17,000 a year earlier but down 18.1% from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Interest & Investment Income (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Intensity Therapeutics reported Interest & Investment Income of $318,000, up 194.4% year-over-year; for FY2025, it came in at $180,000, down 42.7% from FY2024.
- Interest & Investment Income carries a three-year compound annual growth rate of 348.1% (FY2022 to FY2025).
- Going back by year, Interest & Investment Income was $314,000 in FY2024 (-3.1%), $324,000 in FY2023 and $2,000 in FY2022.
- The five-year range for quarterly Interest & Investment Income is $156.00 (Q4 2022) to $176,000 (Q4 2023).
- Year-over-year, Interest & Investment Income has increased for four consecutive quarters, with growth averaging 99.2% over the last eight quarters.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2026 (growth of 526.7%), and the weakest in Q1 2025 (a decline of 89.3%).
- Business Quant data shows INTS's Interest & Investment Income at $94,000 (Q1 2026), $88,000 (Q4 2025) and $59,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Intensity Therapeutics | 10.13 Mn | 10.13 Mn | - | 77,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 176,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Dec 31, 2022 | 156.00 |
| Sep 30, 2022 | 988.00 |
| Jun 30, 2022 | 213.00 |
API Access
Intensity Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();